🔴 Inovio Pharmaceuticals is trading 5% down

Inovio Pharmaceuticals is trading at $1.11, down 5.13%, with no supported explanation for the decline in the available information.

• No September 29 company announcement explaining the decline appeared in INOVIO’s press-release archive; its latest listed releases were investor-conference notices dated September 12 and September 1.
• The broader market was modestly lower, but the provided index moves were below 0.5%, and the available evidence does not establish a market-driven explanation.
• No trading-volume information was provided, so activity level cannot be assessed.